Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

This study contributes to this context by enriching the trust literature, addressing the call to identify key patient-centered technology determinants of trust, advancing the understanding of patient ...

Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.

No specific referral strategies were set up for this study. In each centre, two rheumatologists were involved: R-care and R-blind. R-care took routine care of the patient, ordered diagnostic tests as ...

CCTA has emerged as the preferred non-invasive modality for the study of chest pain due to possible underlying CAD, and for the assessment of cardiovascular risk. Technical advances and realignment of ...

Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

The White House released an expansive report that blames a crisis of chronic disease in children on ultraprocessed foods, chemical exposures, lack of physical activity, stress and excessive use of ...

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximatel ...

We conducted a prospective study ... the patient is taken out of the operating room. The checklist was translated into local language when appropriate and was adjusted to fit into the flow of ...

A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and ...